adenosine has been researched along with Diabetes Mellitus, Type 2 in 87 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (9.20) | 18.2507 |
| 2000's | 22 (25.29) | 29.6817 |
| 2010's | 39 (44.83) | 24.3611 |
| 2020's | 18 (20.69) | 2.80 |
| Authors | Studies |
|---|---|
| Gremmel, T; Huber, K; Panzer, B; Panzer, S; Wadowski, PP | 1 |
| Ahmed, S; Carsons, SE; De Leon, J; Kasselman, L; Reiss, AB; Teboul, I | 1 |
| Han, L; He, Z; Huang, Y; Li, Y; Ong, MTY; Qiu, Y; Situ, C; Wang, G; Wang, H; Wu, Z; Xu, A; Zhang, J; Zhou, S | 1 |
| Jia, Q; Li, Y; Mehmood, S; Yang, R | 1 |
| Donder, E; Karakulak, K; Kaymaz, T; Onalan, E; Onalan, EE; Yakar, B | 1 |
| Bayly, PV; Cho, JH; Hughes, JW; Lee, EY; Li, ZA; Muegge, BD; Roseman, HF; Utterback, T; Woodhams, LG; Zhu, L | 1 |
| Fujita, H; Otomo, H; Takahashi, Y; Yamada, Y | 1 |
| Ahn, Y; Kim, H; Song, G; Song, M; Syafiandini, AF | 1 |
| Cai, Y; Chen, T; Deng, L; Fu, S; Li, C; Wang, M; Xie, K | 1 |
| Benak, D; Benakova, S; Hlavackova, M; Plecita-Hlavata, L | 1 |
| Gang, Q; Gu, Y; Ha, X; Huang, J; Xiao, Q; Zhang, H | 1 |
| Li, SM; Ma, LL; Wang, BH; Xie, W; Xu, YQ | 1 |
| Chan, K; Ip, TP; Lee, CH; Ng, MY; Vardhanabhuti, V; Wan, EYF; Wintersperger, BJ; Yan, AT; Yiu, KH; Yu, EYT; Zhou, W | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Erlinge, D; Pernow, J; Wernly, B; Zhou, Z | 1 |
| Chen, YS; He, PP; Novák, P; Ouyang, XP; Yin, K; Yu, XH; Zhou, L | 1 |
| Avruch, J; Dai, N; Ji, F; Regué, L; Wang, H; Zhao, L | 1 |
| Sanni, O; Terre'Blanche, G | 1 |
| Aldazabal, A; Cerrato, E; Echavarría-Pinto, M; Escaned, J; Fernández-Ortiz, A; Gonzalo, N; Jimenez-Quevedo, P; Macaya, C; Mejia-Renteria, H; Nombela-Franco, L; Núñez-Gil, IJ; Quirós, A; Rumoroso, JR; Ryan, N; Salinas, P | 1 |
| Han, X; Jing, Q; Li, R; Tang, X; Wang, Q; Yang, M; Yu, X; Zhao, J | 1 |
| Baber, U; Badimon, JJ; Contreras, J; Escolar, G; Fuster, V; Linares-Koloffon, CA; Mehran, R; Rey-Mendoza, J; Sartori, S; Smith, DA; Zafar, MU | 1 |
| Cho, JY; Cho, SA; Hong, SJ; Jeong, HS; Joo, HJ; Kim, JH; Lee, SH; Lim, DS; Park, JH; Yu, CW | 1 |
| Ariga, R; Clarke, K; Ferreira, VM; Francis, JM; Greiser, A; Karamitsos, TD; Levelt, E; Liu, A; Mahmod, M; Neubauer, S; Piechnik, SK; Wijesurendra, RS | 1 |
| Cao, PG; Guo, DD; Quan, AJ; Shang, LL; Zhao, HY | 1 |
| Almaça, J; Caicedo, A; Pereira, E; Rodriguez-Diaz, R; Weitz, J | 1 |
| Huang, JT; Huang, W; Liu, SM; Qin, S; Sergi, C; Shen, F; Yang, Y; Yuan, BF | 1 |
| Chibalin, AV; Dolinar, K; Jan, V; Pavlin, M; Pirkmajer, S | 1 |
| Kolluri, N; Lerman, A; Lerman, LO; Sara, JD; Taher, R; Vella, A | 1 |
| Alarcón, S; Niechi, I; Quezada, C; Sobrevia, L; Toledo, F | 1 |
| Dawson, K; Eastridge, K; Gadberry, H; Kincaid, H; Lan, ZJ; Lei, L; Lei, Z; Li, X; Power, C; Power, R; Seale, O; Xiao, R; Yerramreddy, TR; Yiannikouris, A | 1 |
| Alexopoulos, D; Davlouros, P; Mavronasiou, E; Siapika, A; Stavrou, K; Tsoni, E; Xanthopoulou, I | 1 |
| Feng, XH; Gao, W; Han, JL; He, LY; Li, ZP; Yu, J | 1 |
| Braun, AP; Cole, WC; Mishra, RC; Wulff, H | 1 |
| Dahl, JA; Klungland, A | 1 |
| Abdelmoneim, SS; Huang, R; Mulvagh, SL; Nhola, LF | 1 |
| Chen, J; Feng, YQ; Huang, JT; Huang, W; Jia, GF; Liu, SM; Shen, F; Wu, K; Xiong, J; Yang, Y; Yuan, BF | 1 |
| Cataño-Cañizalez, YG; Cortés-Garcia, JD; Cortez-Espinosa, N; Guzman-Flores, JM; Portales-Perez, DP; Rodríguez-Rivera, JG; Vargas-Morales, JM | 1 |
| Bolek, T; Fedor, M; Galajda, P; Kovář, F; Kubisz, P; Mokáň, M; Samoš, M | 1 |
| Berk, BD; Bretón-Romero, R; Duess, MA; Farb, MG; Feng, B; Fetterman, JL; Flint, N; Gokce, N; Hamburg, NM; Holbrook, M; Linder, EA; Shirihai, OS; Vita, JA | 1 |
| Banovic, M; Beleslin, B; Brkovic, V; Djordjevic-Dikic, A; Nedeljkovic, I; Nedeljkovic, M; Nikolic, S; Popovic, D; Ristic, A | 1 |
| Ditmarsch, M; Held, P; Himmelmann, A | 1 |
| Aggarwal, N; Angiolillo, DJ; Bass, TA; Been, L; Cho, JR; Duarte, VE; Durairaj, A; Franchi, F; Hu, J; Kureti, M; Rollini, F; Zenni, MM | 1 |
| Barbato, E; Colaiori, I; Di Sciascio, G; Lauria Pantano, A; Mangiacapra, F; Panaioli, E; Pozzilli, P; Ricottini, E | 1 |
| Guo, X; Ji, S; Ji, X; Wei, W | 1 |
| Cadenas, J; Facta, AD; Goldin, J; Li, Y; Prior, JO; Sayre, J; Schelbert, HR; Schindler, TH; Zhang, XL | 1 |
| Bravo, PE; Hage, FG; Heo, J; Iskandrian, AE; Woodham, RM | 1 |
| Hu, P; Li, P; Liang, QL; Luo, GA; Wang, YM; Xia, JF | 1 |
| Alibegovic, AA; Dela, F; Højbjerre, L; Sonne, MP; Stallknecht, B; Vaag, A | 1 |
| Barrett, EJ; Chyun, DA; Davey, JA; Filipchuk, N; Heller, GV; Inzucchi, SE; Iskandrian, AE; Ratner, RE; Taillefer, R; Wackers, FJ; Wittlin, SD; Young, LH | 2 |
| Shah, PK | 1 |
| Boushel, R; Dela, F; Olsen, DB; Reving, D; Scheede-Bergdahl, C | 1 |
| Sechtem, U; Yilmaz, A | 1 |
| Bune, LT; Hellsten, Y; Pilegaard, H; Rosenmeier, JB; Saltin, B; Thaning, P | 1 |
| Abreu-Vieira, G; Bischoff, LB; Casali, EA; Harthmann, AD; Rücker, B; Sarkis, JJ; Wink, MR | 1 |
| Angiolillo, DJ; Cornel, JH; Erlinge, D; Husted, S; James, S; Kontny, F; Maya, J; Nicolau, JC; Spinar, J; Stevens, SR; Storey, RF; Wallentin, L | 1 |
| Athayde, ML; Bellé, LP; Boligon, A; De Bona, KS; Moretto, MB; Morsch, VM; Pigatto, AS; Sari, MH; Schetinger, MR; Thomé, G | 1 |
| Bune, LT; Rosenmeier, JB; Saltin, B; Thaning, P; Zaar, M | 1 |
| Alibegovic, AC; Dela, F; Højbjerre, L; Nielsen, LB; Sonne, MP; Stallknecht, B; Vaag, AA | 1 |
| Atta, M; Fontecave, M; Fujimura, A; Kaitsuka, T; Kimura, S; Matsui, H; Michiue, H; Suzuki, T; Tomizawa, K; Watanabe, S; Wei, FY; Yamagata, K | 1 |
| Abdel-Kader, SS; Abdelmoneim, SS; Basu, A; Bernier, M; Dhoble, A; Mulvagh, SL; Pellikka, PA | 1 |
| Hua, Z; Wang, S; Wang, Z; Zhang, J; Zhang, Y; Zhao, M; Zhao, Y | 1 |
| Atar, D; Serebruany, VL | 1 |
| Bansal, S; Chyun, DA; Hage, FG; Inzucchi, SE; Iskandrian, AE; Wackers, FJ; Young, LH | 1 |
| Chia, JS; Cowan, PJ; Dwyer, KM; McRae, JL | 1 |
| Mamedova, SI; Petrenko, IV; Petrenko, OA; Popova, MA; Urvantseva, IA | 1 |
| Abletshauser, C; Bengel, FM; Momose, M; Nekolla, SG; Neverve, J; Schnell, O; Schwaiger, M; Standl, E | 1 |
| Higaki, J; Ikegami, H; Kamide, K; Komai, N; Masuyama, T; Nagai, M; Nishikage, T; Ogihara, T; Rakugi, H; Shintani, M; Takiuchi, S | 1 |
| Bagi, Z; Kaley, G; Koller, A | 1 |
| Bhattacharyya, T; Daher, E; DiCarli, MF; Grunberger, G; McMahon, GT; Plutzky, J | 1 |
| Fowler, A; Galiñanes, M; Hassouna, A; Loubani, M; Matata, BM; Standen, NB | 1 |
| Aasum, E; Bratkovsky, SV; Larsen, TS; Myhre, ES; Riemersma, RA | 1 |
| Ellard, S; Harries, LW; Hattersley, A; Singh, R | 1 |
| Antic, S; Lazarević, G; Milojkovic, M; Stefanovic, V; Vlahovic, P | 1 |
| Buus, NH; Bøtker, HE; Bøttcher, M; Madsen, MM; Nielsen, TT; Schmitz, O; Søndergaard, HM | 1 |
| Müller, CE; Rüsing, D; Verspohl, EJ | 1 |
| Carneiro, FS; Carneiro, ZN; Giachini, FRC; Inscho, EW; Leite, R; Lima, VV; Tostes, RC; Webb, RC | 1 |
| Bailbe, D; Giroix, MH; Leclercq-Meyer, V; Malaisse, WJ; Portha, B; Sener, A | 1 |
| Kashiwagi, A | 1 |
| Polonsky, KS; Pugh, W; Tang, J; Zhang, H | 1 |
| Gäbel, J; Lebrun, P; Malaisse, WJ; Pirotte, B; Rorsman, P; Valverde, I; Van Poelje, PD; Villanueva-Peñacarrillo, ML; Viñambres, C | 1 |
| Malaisse, WJ | 1 |
| Gür, S | 1 |
| Danhof, M; Ijzerman, AP; Langemeijer, MW; Tukker, HE; van Schaick, EA; Zuideveld, KP | 1 |
| De Sole, P; Ghirlanda, G; Giardina, B; Marra, G; Persichilli, S; Pitocco, D; Zappacosta, B | 1 |
| Bakker, SJ; Gans, RO; Heine, RJ; Teerlink, T; ter Maaten, JC; Westerhoff, HV | 1 |
| Farouque, HM; Meredith, IT; Skyrme-Jones, RA; Worthley, SG; Zhang, MJ | 1 |
15 review(s) available for adenosine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The role of m
Topics: Adenosine; Diabetes Mellitus, Type 2; Humans; RNA; RNA Processing, Post-Transcriptional; RNA, Messenger | 2023 |
N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism.
Topics: Adenosine; Diabetes Mellitus, Type 2; Humans; RNA; Signal Transduction | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Ticagrelor: a cardiometabolic drug targeting erythrocyte-mediated purinergic signaling?
Topics: Adenosine; Adenosine Triphosphate; Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Erythrocytes; Humans; Purinergic Agonists; Signal Transduction; Ticagrelor | 2021 |
N6-Adenosine Methylation (m
Topics: Adenosine; Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Methylation; RNA, Messenger | 2021 |
Therapeutic potentials of agonist and antagonist of adenosine receptors in type 2 diabetes.
Topics: Adenosine; Diabetes Mellitus, Type 2; Glucose; Homeostasis; Humans; Receptors, Purinergic P1 | 2021 |
Glioma progression in diabesity.
Topics: Adenosine; Antineoplastic Agents; Brain Neoplasms; Diabetes Mellitus, Type 2; Disease Progression; Gene Regulatory Networks; Glioma; Humans; Hypoglycemic Agents; Obesity; Risk Factors; Up-Regulation | 2019 |
Dynamic RNA modifications in disease.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Diabetes Mellitus, Type 2; Dioxygenases; Humans; Membrane Proteins; Methyltransferases; Mutation; Obesity; Proteins; RNA, Messenger | 2014 |
Type 2 Diabetes and ADP Receptor Blocker Therapy.
Topics: Adenosine; Adenosine Monophosphate; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Diabetes Mellitus, Type 2; Drug Resistance; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Factors; Ticagrelor; Ticlopidine; Treatment Outcome | 2016 |
Ticagrelor for the treatment of atherosclerotic disease: insights from the PARTHENON clinical development program.
Topics: Acute Coronary Syndrome; Adenosine; Atherosclerosis; Diabetes Mellitus, Type 2; Humans; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Ticagrelor; Treatment Outcome | 2016 |
Regulatory Role of N
Topics: Adenosine; Animals; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Methylation; Neoplasms; Obesity; RNA Processing, Post-Transcriptional; RNA, Neoplasm | 2017 |
[Risk prediction using cardiovascular magnetic resonance imaging].
Topics: Adenosine; Cardiotonic Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dobutamine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Risk Assessment; Vasodilator Agents | 2009 |
The CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetes.
Topics: Adenosine; Animals; Antigens, CD; Apyrase; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Pancreas; Signal Transduction | 2012 |
Rationale and hurdles of inhibitors of hepatic gluconeogenesis in treatment of diabetes mellitus.
Topics: Adenosine; Adipocytes; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Gluconeogenesis; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Lipolysis; Liver; Male; Models, Biological; Rats; Rats, Inbred Strains | 1995 |
Regulation, perturbation, and correction of metabolic events in pancreatic islets.
Topics: Adenosine; Animals; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucokinase; Glycerolphosphate Dehydrogenase; Hexoses; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Mitochondria; Oxidative Phosphorylation; Peptide Fragments; Protein Precursors; Sulfonylurea Compounds | 1996 |
18 trial(s) available for adenosine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Methotrexate effects on adenosine receptor expression in peripheral monocytes of persons with type 2 diabetes and cardiovascular disease.
Topics: Adenosine; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Gene Expression; Humans; Inflammation; Leukocytes, Mononuclear; Methotrexate; Monocytes; Myocardial Infarction; Receptors, Purinergic P1 | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
PRotective Effect on the coronary microcirculation of patients with DIabetes by Clopidogrel or Ticagrelor (PREDICT): study rationale and design. A randomized multicenter clinical trial using intracoronary multimodal physiology.
Topics: Adenosine; Blood Platelets; Clinical Protocols; Clopidogrel; Coronary Artery Disease; Coronary Circulation; Diabetes Mellitus, Type 2; Humans; Microcirculation; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Research Design; Risk Factors; Spain; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Vasodilation | 2017 |
The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.
Topics: Adenosine; Aged; Alanine Transaminase; Aspartate Aminotransferases; Aspirin; Blood Glucose; Cardiac Output; China; Creatine Kinase; Creatine Kinase, MB Form; Creatinine; Diabetes Mellitus, Type 2; Echocardiography; Female; Glycated Hemoglobin; Heart Atria; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Stroke Volume; Ticagrelor; Treatment Outcome; Trimetazidine; Troponin I; Urea; Vasodilator Agents | 2017 |
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease.
Topics: Adenosine; Aged; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Coronary Thrombosis; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting: A Prospective, Randomized,
Topics: Acute Coronary Syndrome; Adenosine; Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Brachial Artery; Cross-Over Studies; Diabetes Mellitus, Type 2; Endothelial Progenitor Cells; Female; Humans; Inflammation Mediators; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Seoul; Stents; Ticagrelor; Time Factors; Treatment Outcome; Vasodilation | 2017 |
Comparison of pharmacodynamic effects of ticagrelor vs prasugrel in type 2 diabetes mellitus patients with coronary heart disease.
Topics: Adenosine; Aged; Aspirin; Coronary Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Thrombosis; Ticagrelor; Time Factors | 2018 |
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with diabetes.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Single-Blind Method; Thiophenes; Ticagrelor; Ticlopidine | 2013 |
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
Topics: Adenosine; Adolescent; Adult; Aged; Coronary Artery Disease; Cross-Over Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Ticagrelor | 2016 |
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients).
Topics: Adenosine; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor; Ticlopidine | 2016 |
Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.
Topics: Adenosine; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Vasodilator Agents | 2009 |
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Blood Glucose; Clopidogrel; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticagrelor; Ticlopidine; Treatment Outcome | 2010 |
Syzygium cumini extract decrease adenosine deaminase, 5'nucleotidase activities and oxidative damage in platelets of diabetic patients.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Deaminase; Blood Platelets; Catalase; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Myrtaceae; Oxidative Stress; Plant Extracts; Plant Leaves; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2010 |
Functional sympatholysis during exercise in patients with type 2 diabetes with intact response to acetylcholine.
Topics: Acetylcholine; Adenosine; Adenosine Triphosphate; Age Factors; Diabetes Mellitus, Type 2; Exercise; Female; Humans; Hyperemia; Male; Middle Aged; Muscle, Skeletal; Regional Blood Flow; Vasoconstriction | 2011 |
The heart rate response to adenosine: a simple predictor of adverse cardiac outcomes in asymptomatic patients with type 2 diabetes.
Topics: Adenosine; Aged; Asymptomatic Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Heart Diseases; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Treatment Outcome | 2013 |
Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus.
Topics: Adenosine; Blood Flow Velocity; Cold Temperature; Coronary Circulation; Coronary Disease; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Heart; Hemostasis; Humans; Male; Microcirculation; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetes.
Topics: Adenosine; Aged; Coronary Circulation; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Pilot Projects; Pioglitazone; Positron-Emission Tomography; PPAR gamma; Predictive Value of Tests; Thiazolidinediones; Vascular Resistance | 2005 |
Effect of ATP-sensitive potassium channel inhibition on resting coronary vascular responses in humans.
Topics: Adenosine; Adenosine Triphosphate; Blood Flow Velocity; Blood Glucose; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Electrocardiography; Female; Glyburide; Humans; Hypoglycemic Agents; Infusions, Intra-Arterial; Insulin; Male; Microcirculation; Middle Aged; Potassium Channel Blockers; Potassium Channels; Vascular Patency | 2002 |
55 other study(ies) available for adenosine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Protease-activated receptor-mediated platelet aggregation in patients with type 2 diabetes on potent P2Y
Topics: Acute Coronary Syndrome; Adenosine; Diabetes Mellitus, Type 2; Humans; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Proteinase-Activated; Ticagrelor | 2022 |
Muscle satellite cells are impaired in type 2 diabetic mice by elevated extracellular adenosine.
Topics: Adenosine; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Humans; Mice; Mice, Inbred Strains; Muscles | 2022 |
Epigallocatechin-3-gallate attenuates myocardial fibrosis in diabetic rats by activating autophagy.
Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Autophagy; Beclin-1; Blood Glucose; Catechin; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Fibrosis; Hydroxyproline; Hypertrophy; Mammals; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microtubule-Associated Proteins; Rats; TOR Serine-Threonine Kinases; Transforming Growth Factor beta1 | 2022 |
m
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Humans; Obesity; RNA; RNA, Messenger | 2022 |
Islet primary cilia motility controls insulin secretion.
Topics: Adenosine; Animals; Calcium; Cilia; Diabetes Mellitus, Type 2; Dyneins; Glucose; Humans; Insulin Secretion; Mice | 2022 |
Dual inhibition of SGLT2 and DPP-4 promotes natriuresis and improves glomerular hemodynamic abnormalities in KK/Ta-Ins2
Topics: Adenosine; Albumins; Animals; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprostone; Dipeptidyl-Peptidase IV Inhibitors; Hemodynamics; Insulin; Linagliptin; Male; Mice; Natriuresis; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
An automatic hypothesis generation for plausible linkage between xanthium and diabetes.
Topics: Adenosine; Biological Products; Choline; Diabetes Mellitus, Type 2; Rhamnose; Scopoletin; Xanthium | 2022 |
N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway.
Topics: Adenosine; Animals; Diabetes Mellitus, Type 2; Glucose; Heterogeneous-Nuclear Ribonucleoprotein Group C; Human Umbilical Vein Endothelial Cells; Humans; Methylation; Mice; Presenilin-1; RNA; Vascular Diseases | 2023 |
METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Topics: Adenosine; Animals; Dependovirus; Diabetes Mellitus, Type 2; Disease Models, Animal; Fatty Acid Synthase, Type I; Fatty Acids; Gene Deletion; Glucose; Hepatocytes; Homeostasis; Humans; Insulin Resistance; Liver; Methylation; Methyltransferases; Mice, Inbred C57BL; Mice, Knockout; Obesity; RNA, Messenger | 2019 |
Cardiac magnetic resonance for asymptomatic patients with type 2 diabetes and cardiovascular high risk (CATCH): a pilot study.
Topics: Adenosine; Aged; Aged, 80 and over; Asymptomatic Diseases; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Diabetes Mellitus, Type 2; Feasibility Studies; Female; Hong Kong; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Pilot Projects; Predictive Value of Tests; Prevalence; Prospective Studies; Reproducibility of Results; Risk Assessment; Risk Factors; Stents; Time Factors; Treatment Outcome; Vasodilator Agents | 2020 |
RNA m6A reader IMP2/IGF2BP2 promotes pancreatic β-cell proliferation and insulin secretion by enhancing PDX1 expression.
Topics: Adenosine; Animals; Cell Line; Cell Proliferation; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gene Knockout Techniques; Homeodomain Proteins; Humans; Insulin Secretion; Insulin-Secreting Cells; Insulin, Regular, Human; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Promoter Regions, Genetic; Rats; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Trans-Activators; Transfection | 2021 |
Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease.
Topics: Adenosine; Adult; Case-Control Studies; Contrast Media; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Early Diagnosis; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Microcirculation; Middle Aged; Myocardial Perfusion Imaging; Observer Variation; Organometallic Compounds; Predictive Value of Tests; Reproducibility of Results; Stroke Volume; Vasodilator Agents; Ventricular Function, Left | 2017 |
The Pericyte of the Pancreatic Islet Regulates Capillary Diameter and Local Blood Flow.
Topics: Adenosine; Adolescent; Adult; Animals; Capillaries; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice; Middle Aged; Pericytes; Regional Blood Flow | 2018 |
Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Blood Glucose; Diabetes Mellitus, Type 2; Diacylglycerol O-Acyltransferase; Female; Forkhead Box Protein O1; Gene Knockdown Techniques; Glucose-6-Phosphatase; Hep G2 Cells; Humans; Male; Methyltransferases; Middle Aged; RNA, Messenger; Up-Regulation | 2019 |
Nucleosides block AICAR-stimulated activation of AMPK in skeletal muscle and cancer cells.
Topics: Adenosine; Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Ascorbic Acid; Cell Line, Tumor; Culture Media; Diabetes Mellitus, Type 2; Energy Metabolism; Glucose; Humans; Muscle, Skeletal; Neoplasms; Nucleosides; Protein Kinases; Ribonucleotides; Thioctic Acid; Vitamin B 12 | 2018 |
Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease.
Topics: Acetylcholine; Adenosine; Adult; Aged; Angina Pectoris; Biomarkers; Blood Glucose; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Echocardiography, Doppler; Female; Fractional Flow Reserve, Myocardial; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Microcirculation; Microvessels; Middle Aged; Minnesota; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Vasoconstrictor Agents; Vasodilator Agents | 2019 |
Non-peptidyl small molecule, adenosine, 5'-Se-methyl-5'-seleno-, 2',3'-diacetate, activates insulin receptor and attenuates hyperglycemia in type 2 diabetic Lepr
Topics: Adenosine; Animals; Diabetes Mellitus, Type 2; Glucose; Hep G2 Cells; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Methylation; Mice; Mice, Inbred C57BL; Organoselenium Compounds; Receptor, Insulin | 2020 |
[Correlation of low density lipoprotein cholesterol with coronary flow reserve in patients with type 2 diabetes].
Topics: Adenosine; Case-Control Studies; Cholesterol, LDL; Coronary Circulation; Diabetes Mellitus, Type 2; Echocardiography, Doppler; Humans | 2014 |
A pharmacologic activator of endothelial KCa channels enhances coronary flow in the hearts of type 2 diabetic rats.
Topics: Adenosine; Age Factors; Animals; Benzothiazoles; Bradykinin; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Heart; Infusion Pumps; Male; Nitroprusside; Organ Culture Techniques; Potassium Channels, Calcium-Activated; Rats; Rats, Wistar | 2014 |
Relationship between HgbA1c and myocardial blood flow reserve in patients with type 2 diabetes mellitus: noninvasive assessment using real-time myocardial perfusion echocardiography.
Topics: Adenosine; Aged; Biomarkers; Blood Flow Velocity; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Echocardiography, Stress; Female; Fractional Flow Reserve, Myocardial; Glycated Hemoglobin; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Perfusion Imaging; Odds Ratio; Predictive Value of Tests; Prospective Studies; Regional Blood Flow; Risk Factors; Vasodilator Agents | 2014 |
Decreased N(6)-methyladenosine in peripheral blood RNA from diabetic patients is associated with FTO expression rather than ALKBH5.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Biomarkers; Diabetes Mellitus, Type 2; Dioxygenases; Epigenesis, Genetic; Female; Humans; Male; Membrane Proteins; Proteins; Rats | 2015 |
Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus.
Topics: 5'-Nucleotidase; Adenosine; Adult; Antigens, CD; Apoptosis; Apyrase; Body Mass Index; CD8-Positive T-Lymphocytes; Diabetes Mellitus, Type 2; Gene Expression Regulation; GPI-Linked Proteins; Humans; Inflammation; Lymphocyte Subsets; Lymphocytes; Obesity; Phenethylamines; Receptor, Adenosine A2A; Triazines; Triazoles | 2015 |
Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling.
Topics: Adenosine; Adult; Aged; Autophagy; Biomarkers; Case-Control Studies; Cell Separation; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelial Cells; Female; Humans; Macrolides; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Signal Transduction; Spermidine | 2016 |
Diabetes mellitus and coronary microvascular function in asymptomatic patients with severe aortic stenosis and nonobstructed coronary arteries.
Topics: Adenosine; Aged; Aortic Valve Stenosis; Asymptomatic Diseases; Case-Control Studies; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Echocardiography, Doppler; Echocardiography, Stress; Female; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Microvessels; Middle Aged; Prognosis; Risk Factors; Severity of Illness Index; Stroke Volume; Time Factors; Vasodilator Agents; Ventricular Function, Left | 2016 |
Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus.
Topics: Adenosine; Adult; Calcinosis; Carotid Arteries; Cold Temperature; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Rest; Sympathetic Nervous System; Vasodilation | 2009 |
Heart rate response to adenosine in patients with diabetes mellitus and normal myocardial perfusion imaging.
Topics: Adenosine; Aged; Diabetes Mellitus, Type 2; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Prognosis; Severity of Illness Index; Systole; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Left | 2008 |
Correlations of six related purine metabolites and diabetic nephropathy in Chinese type 2 diabetic patients.
Topics: Adenosine; Aged; Asian People; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Inosine; Male; Middle Aged; Purines; Uric Acid; Xanthine | 2009 |
Impaired endothelial function and insulin action in first-degree relatives of patients with type 2 diabetes mellitus.
Topics: Acetylcholine; Adenosine; Adult; Blood Gas Analysis; Blood Glucose; C-Peptide; C-Reactive Protein; Cholesterol; Diabetes Mellitus, Type 2; Endothelium, Vascular; Family; Glucose Clamp Technique; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Plethysmography; Potassium; Statistics, Nonparametric; Vascular Resistance; Vasodilator Agents | 2009 |
Diabetes: Does screening for inducible ischemia improve outcomes?
Topics: Adenosine; Diabetes Mellitus, Type 2; Humans; Mass Screening; Myocardial Ischemia; Myocardial Perfusion Imaging; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome | 2009 |
Insulin and non-insulin mediated vasodilation and glucose uptake in patients with type 2 diabetes.
Topics: Acetylcholine; Adenosine; Blood Flow Velocity; Blood Glucose; Blood Pressure; Brachial Artery; Diabetes Mellitus, Type 2; Endothelium, Vascular; Half-Life; Humans; Hypoglycemic Agents; Infusions, Intra-Arterial; Insulin; Middle Aged; Nitroprusside; Oxygen Consumption; Reference Values; Vasodilation; Vasodilator Agents | 2009 |
Attenuated purinergic receptor function in patients with type 2 diabetes.
Topics: Adenosine; Adenosine Triphosphate; Blood Flow Velocity; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Exercise; Female; Humans; Leg; Male; Middle Aged; Muscle, Skeletal; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2Y2; Reference Values; Regional Blood Flow; Uridine Triphosphate; Vasodilation | 2010 |
The nucleotide hydrolysis is altered in blood serum of streptozotocin-induced diabetic rats.
Topics: Adenosine; Adenosine Triphosphatases; Animals; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hydrolysis; Male; Nucleotides; Rats; Rats, Wistar; Serum; Streptozocin | 2010 |
Endothelial function after 10 days of bed rest in individuals at risk for type 2 diabetes and cardiovascular disease.
Topics: Acetylcholine; Adenosine; Adult; Bed Rest; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Endothelium, Vascular; Forearm; Homocysteine; Humans; Hyperinsulinism; Infant, Low Birth Weight; Infant, Newborn; Insulin; Intercellular Adhesion Molecule-1; Male; Regional Blood Flow; Risk; Vascular Cell Adhesion Molecule-1; Vasodilation | 2011 |
Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice.
Topics: Adenosine; Animals; Cell Line; Cyclin-Dependent Kinase 5; Diabetes Mellitus, Type 2; Genes, Reporter; Glucagon; Glucose; HEK293 Cells; Humans; Mice; Mice, Knockout; Mice, Transgenic; Nerve Tissue Proteins; Nucleic Acid Conformation; Proinsulin; Protein Biosynthesis; Recombinant Fusion Proteins; RNA, Transfer, Amino Acyl; Threonine; tRNA Methyltransferases | 2011 |
Detection of myocardial microvascular disease using contrast echocardiography during adenosine stress in type 2 diabetes mellitus: prospective comparison with single-photon emission computed tomography.
Topics: Adenosine; Aged; Aged, 80 and over; Contrast Media; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Echocardiography, Stress; Female; Humans; Male; Microcirculation; Middle Aged; Minnesota; Myocardial Perfusion Imaging; Predictive Value of Tests; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2011 |
The plasma 5'-AMP acts as a potential upstream regulator of hyperglycemia in type 2 diabetic mice.
Topics: Adenosine; Adenosine Monophosphate; Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glycogenolysis; Human Umbilical Vein Endothelial Cells; Humans; Hyperglycemia; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Muscle, Skeletal; Necrosis; Protein Isoforms; Receptors, Purinergic P1 | 2012 |
Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials--common patterns in TRITON, RECORD, and PLATO?
Topics: Acute Coronary Syndrome; Adenosine; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Judgment; Metformin; Multicenter Studies as Topic; Myocardial Infarction; Observer Variation; Outcome Assessment, Health Care; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Process Assessment, Health Care; Randomized Controlled Trials as Topic; Rosiglitazone; Stroke; Sulfonylurea Compounds; Thiazolidinediones; Thiophenes; Ticagrelor | 2012 |
[The incidence of postoperative myocardial infarction and the left ventricular function in patients with type 2 diabetes mellitus after recanalization of chronic coronary occlusions].
Topics: Adenosine; Chronic Disease; Comorbidity; Coronary Occlusion; Diabetes Mellitus, Type 2; Humans; Incidence; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Placebos; Postoperative Complications; Vasodilator Agents; Ventricular Function, Left | 2012 |
Hypertension attenuates the efficacy of hypoglycemic therapy for preserving coronary flow reserve in patients with type 2 diabetes.
Topics: Adenosine; Adenosine Triphosphate; Aged; Coronary Circulation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Echocardiography; Female; Hemodynamics; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Vasodilator Agents | 2002 |
PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes.
Topics: Acetylcholine; Adenosine; Animals; Arterioles; Biological Availability; Coronary Vessels; Diabetes Mellitus, Type 2; Disease Models, Animal; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Oxidative Stress; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Vasodilation | 2004 |
Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium.
Topics: Adenosine; Adrenergic alpha-Agonists; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diazoxide; Enzyme Activation; Glyburide; Heart Atria; Humans; Hypoglycemic Agents; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Membrane Potentials; Metformin; Mitochondria, Heart; Myocardial Ischemia; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Potassium Channels; Protein Kinase C; Reactive Oxygen Species; Tetradecanoylphorbol Acetate | 2006 |
Reduced coronary reserve in response to short-term ischaemia and vasoactive drugs in ex vivo hearts from diabetic mice.
Topics: Adenosine; Animals; Body Weight; Coronary Circulation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Lauric Acids; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Nitroprusside; Organ Culture Techniques; Vasodilator Agents | 2006 |
Rapid and sensitive real-time polymerase chain reaction method for detection and quantification of 3243A>G mitochondrial point mutation.
Topics: Adenosine; Alleles; Diabetes Mellitus, Type 2; DNA, Mitochondrial; Guanosine; Humans; Point Mutation; Polymerase Chain Reaction; Time Factors | 2006 |
Lymphocyte ecto-5'-nucleotidase in obese type 2 diabetic patients treated with gliclazide.
Topics: 5'-Nucleotidase; Adenosine; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Gliclazide; Humans; Hypoglycemic Agents; Lymphocytes; Middle Aged; Obesity; Triglycerides | 2006 |
Impact of type 2 diabetes on nitric oxide and adrenergic modulation of myocardial perfusion.
Topics: Adenosine; Adrenergic alpha-Antagonists; Blood Pressure; Coronary Circulation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Heart Rate; Humans; Hyperemia; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phentolamine; Sympathetic Nervous System; Vascular Resistance; Vasodilator Agents | 2007 |
The impact of adenosine and A(2B) receptors on glucose homoeostasis.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Analysis of Variance; Animals; Antineoplastic Agents; Blood Glucose; Cell Line, Tumor; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Homeostasis; Insulin; Male; Phenethylamines; Radioimmunoassay; Rats; Rats, Wistar; Receptor, Adenosine A2B; Sulfonic Acids; Xanthines | 2006 |
Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study.
Topics: Adenosine; Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Prevalence; Racial Groups; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2007 |
Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse.
Topics: Acetylcholine; Adenosine; Adenosine Kinase; Animals; Diabetes Mellitus, Type 2; Dipyridamole; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Male; Mice; Mice, Mutant Strains; Mice, Obese; Muscle Contraction; Muscle, Smooth; Nitroprusside; Penis; Phenylephrine; Phosphodiesterase Inhibitors; Tubercidin; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
Metabolic, ionic, and secretory response to D-glucose in islets from rats with acquired or inherited non-insulin-dependent diabetes.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Diabetes Mellitus, Type 2; Glucose; Islets of Langerhans; Phosphates; Pyruvates; Pyruvic Acid; Rats; Rats, Wistar; Rubidium Radioisotopes; Streptozocin | 1993 |
Preservation of insulin secretory responses to P2 purinoceptor agonists in Zucker diabetic fatty rats.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Analysis of Variance; Animals; Blood Glucose; Body Weight; Calcium; Diabetes Mellitus; Diabetes Mellitus, Type 2; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Obesity; Perfusion; Potassium Chloride; Purinergic P2 Receptor Agonists; Rats; Rats, Wistar; Rats, Zucker; Reference Values; Thionucleotides; Time Factors | 1996 |
The riddle of formycin A insulinotropic action.
Topics: Adenosine; Animals; Calcium; Diabetes Mellitus, Type 2; Diazoxide; Female; Formycins; Glucose; Glyburide; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Rats; Ribonucleotides; Tubercidin; Verapamil; Xanthines | 1996 |
Effects of adenosine and isoprenaline in left atria from both neonatal and middle-aged noninsulin-dependent diabetic rat models.
Topics: Adenosine; Aging; Animals; Animals, Newborn; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Heart Atria; In Vitro Techniques; Insulin; Isoproterenol; Male; Myocardial Contraction; Rats; Streptozocin; Triglycerides | 1997 |
Metabolic and cardiovascular effects of the adenosine A1 receptor agonist N6-(p-sulfophenyl)adenosine in diabetic Zucker rats: influence of the disease on the selectivity of action.
Topics: Adenosine; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Hemodynamics; Insulin; Lipolysis; Male; Obesity; Purinergic P1 Receptor Agonists; Rats; Rats, Zucker | 1998 |
Purine metabolites and malondialdehyde in platelets of diabetic patients.
Topics: Adenosine; Adenosine Monophosphate; Adolescent; Adult; Aged; Blood Platelets; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Guanine Nucleotides; Humans; Male; Malondialdehyde; Middle Aged; Purines; Reference Values | 1999 |
The potential role of adenosine in the pathophysiology of the insulin resistance syndrome.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adipose Tissue; Animals; Coronary Disease; Diabetes Mellitus, Type 2; Erythropoiesis; Fatty Acids; Heart Rate; Hematocrit; Humans; Hyperinsulinism; Hypertrophy; Insulin Resistance; Islets of Langerhans; Mitochondria; Mitochondrial ADP, ATP Translocases; Models, Biological; Natriuresis; Obesity; Oxidative Phosphorylation; Renal Circulation; Risk Factors; Sodium; Superoxides; Sympathetic Nervous System; Uric Acid; Vasodilation | 2001 |